Covered recipient · General Payments record
KATHRYN MARIANA LITT
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$1,512.08
- Reported across 94 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $297.59 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $115.64 | 6 |
| Sage Therapeutics, Inc. | $66.58 | 2 |
| Organon LLC | $46.98 | 6 |
| Sumitomo Pharma America, Inc. | $26.84 | 1 |
| Exeltis, USA Inc. | $22.20 | 1 |
| MILLICENT US INC | $19.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $17.96 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139288660 | CMS |
| Astellas Pharma US Inc | $21.11 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139292976 | CMS |
| Astellas Pharma US Inc | $20.61 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139311374 | CMS |
| Astellas Pharma US Inc | $16.50 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139323616 | CMS |
| Astellas Pharma US Inc | $18.79 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139352881 | CMS |
| Astellas Pharma US Inc | $20.67 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139394815 | CMS |
| Exeltis, USA Inc. | $22.20 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149998050 | CMS |
| MILLICENT US INC | $19.35 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150909215 | CMS |
| Organon Llc | $2.97 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136212597 | CMS |
| Organon Llc | $12.10 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136212599 | CMS |
| Organon Llc | $0.66 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136212601 | CMS |
| Organon Llc | $13.55 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136212603 | CMS |
| Organon Llc | $0.66 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136212605 | CMS |
| Organon Llc | $17.04 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136212607 | CMS |
| Sage Therapeutics, Inc. | $34.92 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120400750 | CMS |
| Sage Therapeutics, Inc. | $31.66 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120400752 | CMS |
| Sumitomo Pharma America, Inc. | $26.84 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148882592 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.